Acumen Pharmaceuticals ABOS
NASDAQ ABOS
$2.11 +0.08 (+3.94%)
As of: Oct 22, 2026 · 10:56 AM EDT

Acumen Pharmaceuticals (ABOS) Return on Assets [ROA] (2021 - 2026)

Updated

Acumen Pharmaceuticals (ABOS) posted Return on Assets [ROA] of -83.80% for Q2 2026, down 10.93 percentage points from -72.87% a year earlier but up 4.20 percentage points from the prior quarter.

Analysis

Acumen Pharmaceuticals (ABOS) Return on Assets [ROA] (2021 - 2026) Analysis & Trends

For FY2025, Acumen Pharmaceuticals' Return on Assets [ROA] came in at -66.67%, down 28.87 percentage points from FY2024.

  • Annual Return on Assets [ROA] shows a four-year change of -52.41 percentage points (FY2021 to FY2025).
  • In prior years, Acumen Pharmaceuticals' Return on Assets [ROA] was -37.79% in FY2024 (-17.69 pp), -20.10% in FY2023 (+1.09 pp), -21.19% in FY2022 (-6.94 pp) and -14.26% in FY2021.
  • Quarterly Return on Assets [ROA] has run from a low of -91.01% in Q4 2025 to a high of -8.12% in Q3 2021 over five years.
  • On a year-over-year basis, Return on Assets [ROA] has declined in each of the last eight quarters, with an average year-over-year change of -33.50 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q1 2024, with a gain of 7.77 percentage points; the weakest was Q3 2025, with a drop of 55.63 percentage points.
  • According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -88.00% (Q1 2026), -91.01% (Q4 2025) and -84.86% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,167.56 Bn 1,136.14 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 635.76 Bn 554.29 Bn 17.26 Bn 10.47%
3 AbbVie 503.27 Bn 476.38 Bn 12.70 Bn 4.65%
4 Merck 377.51 Bn 331.89 Bn 12.21 Bn 2.45%
5 Novartis Ag 304.07 Bn 268.06 Bn 11.24 Bn 10.60%
6 Astrazeneca 267.53 Bn 241.22 Bn 12.86 Bn 9.10%
7 Amgen 242.06 Bn 197.46 Bn 7.24 Bn 9.29%
8 Gilead Sciences 194.26 Bn 168.46 Bn 6.22 Bn -6.13%
9 Pfizer 172.62 Bn 119.27 Bn 10.94 Bn 2.14%
10 Acumen Pharmaceuticals 153.16 Mn -328.90 Mn - -83.80%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -83.80%
Mar 31, 2026 -88.00%
Dec 31, 2025 -91.01%
Sep 30, 2025 -84.86%
Jun 30, 2025 -72.87%
Mar 31, 2025 -53.18%
Dec 31, 2024 -41.02%
Sep 30, 2024 -29.23%
Jun 30, 2024 -21.82%
Mar 31, 2024 -17.80%
Dec 31, 2023 -17.69%
Sep 30, 2023 -22.38%
Jun 30, 2023 -27.57%
Mar 31, 2023 -25.58%
Dec 31, 2022 -22.63%
Sep 30, 2022 -18.99%
Jun 30, 2022 -14.80%
Mar 31, 2022 -11.09%
Dec 31, 2021 -8.41%
Sep 30, 2021 -8.12%
API Access

Acumen Pharmaceuticals Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ABOS&period=max&api_key=YOUR_API_KEY